She stated that the aim of this project is to carry out pioneering studies in the development of a new diagnostic and therapeutic agent for MS by determining the MS relationship and related metabolome changes through the pentose-phosphate pathway, which is seen as the brain of metabolism of the therapeutic or prophylactic effect of the probiotic.